From: MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway
Variables | Hazard ratio | 95% confidence interval | P value |
---|---|---|---|
Age (> 45 vs ≤ 45) | 0.754 | 0.460–1.237 | 0.264 |
Gender (male vs female) | 1.084 | 0.618–1.900 | 0.779 |
Tumor differentiation (III–IV vs I–II) | 1.939 | 1.204–3.120 | 0.006* |
Microvascular invasion (positive vs negative) | 1.688 | 0.985–2.894 | 0.057 |
TNM stage (III–IV vs I–II) | 0.585 | 0.357–0.960 | 0.034* |
MKP-4 (low vs high) | 0.175 | 0.086–0.355 | < 0.001* |
ERK1/2 (low vs high) | 2.120 | 1.137–3.953 | 0.018* |
p-ERK1/2 (low vs high) | 2.482 | 1.375–4.482 | 0.003* |